UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP

科罗拉多大学西南肿瘤学组

• 批准号: 6137445
• 负责人: SCOTT I BEARMAN
• 金额: $ 37.2万
• 依托单位: UNIVERSITY OF COLORADO DENVER
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-01-21 至 2002-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6137445
• 关键词: antineoplastics; bleomycin; bone marrow transplantation; brain neoplasms; breast neoplasms; cancer information system; cancer prevention; cancer registry /resource; cis platinum compound; clinical research; clinical trials; combination cancer therapy; combination chemotherapy; cooperative study; cyclophosphamide; doxorubicin; drug resistance; female reproductive system neoplasm; fludarabine; gastrointestinal neoplasms; head /neck neoplasm; hormone therapy; human subject; human therapy evaluation; ifosfamide; leukemia; lung neoplasms; lymphoma; meeting /conference /symposium; melanoma; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; neoplasm /cancer epidemiology; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; oncology nursing; paclitaxel; pancreas neoplasms; pathology; prognosis; prostate neoplasms; quality of life; sarcoma; tamoxifen; tissue resource /registry; urinary tract neoplasms; women's health

Description (Adapted from the applicant s abstract): The University of Colorado Cancer Center is requesting continuing support for their participation in the Southwest Oncology Group (SWOG). The mission of the University of Colorado Cancer Center has, since it's founding, been the reduction of cancer mortality through basic laboratory research, moving scientific discoveries to the clinic through translational research, and the design, execution, and analysis of clinical trials. Their participation in SWOG has been an integral part of the mission of the University of Colorado Cancer Center. Institutional pilot studies conducted at the University of Colorado have been brought to the Group in the form of prospective randomized trials. SWOG members from the University of Colorado have and continue to contribute to the administrative, educational and scientific functions of SWOG. University of Colorado SWOG members are chairs or co-chairs of the following committees: Genitourinary (Dr. E. David Crawford), Blood and Marrow Transplantation (Dr. Elizabeth Shpall), GU Pathology (Dr. Gary Miller), and Lung Biology (Wilbur Franklin). Dr. Scott Bearman is Principal Investigator for SWOG and sits on the Board of Governors. In addition to these administrative contributions, University of Colorado Cancer Center members are coordinators or co-coordinators of 17 percent of the SWOG protocols activated during the previous grant period. Presently, University of Colorado members are important contributors to the Blood and Marrow Transplantation, Breast, Lung, and GU Committees. During the next five years they expect to continue to make important scientific and administrative contributions to those committees. In addition, they expect to contribute in other areas as well, including radiotherapy (Drs. Rachel Rabinovitch and Michael Weil), developmental therapeutics (Dr. Andrew Kraft), neuro-oncology (Dr. Bertrand Liang) and Cancer Control (Dr. Marie Wood). They are proud of our contributions to the Southwest Oncology Group and are committed to its mission. They expect their contributions to increase during the next 5 years.

描述（根据申请人的摘要改编）： 科罗拉多癌症中心要求继续为他们的 参加西南肿瘤学小组（SWOG）。 任务 科罗拉多大学癌症中心自成立以来一直是 通过基本实验室研究降低癌症死亡率，移动 通过转化研究向诊所的科学发现， 临床试验的设计，执行和分析。 他们参与 Swog一直是科罗拉多大学任务不可或缺的一部分 癌症中心。 在大学进行的机构试点研究 科罗拉多州以潜在的形式将科罗拉多州带到了小组 随机试验。 科罗拉多大学有和 继续为行政，教育和科学贡献 摇摆的功能。 科罗拉多大学摇摆成员是椅子或 以下委员会的联合主席：泌尿生殖器（E. David博士 Crawford），血液和骨髓移植（Elizabeth Shpall博士），GU 病理学（加里·米勒博士）和肺生物学（威尔伯·富兰克林）。 斯科特博士 Bearman是Swog的首席调查员，坐在 州长。 除了这些行政贡献， 科罗拉多州癌症中心成员是17的协调员或协调员 在上一个赠款期间激活了SWOG协议的百分比。 目前，科罗拉多大学成员是对 血液和骨髓移植，乳房，肺部和GU委员会。 期间 接下来的五年，他们期望继续进行重要的科学和 对这些委员会的行政捐款。 此外，他们期望 在其他领域也有贡献，包括放射治疗（雷切尔博士 Rabinovitch和Michael Weil），发育治疗学（安德鲁博士 Kraft），神经肿瘤学（Bertrand Liang博士）和癌症控制（Marie博士 木头）。 他们为我们对西南肿瘤学小组的贡献感到自豪 并致力于其使命。 他们期望自己的贡献 在接下来的5年中增加。